These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 33945304)

  • 1. Continuous Glucose Monitoring Time-in-Range and HbA
    Tundidor D; Meek CL; Yamamoto J; Martínez-Bru C; Gich I; Feig DS; Murphy HR; Corcoy R;
    Diabetes Technol Ther; 2021 Oct; 23(10):710-714. PubMed ID: 33945304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol.
    Feig DS; Asztalos E; Corcoy R; De Leiva A; Donovan L; Hod M; Jovanovic L; Keely E; Kollman C; McManus R; Murphy K; Ruedy K; Sanchez JJ; Tomlinson G; Murphy HR;
    BMC Pregnancy Childbirth; 2016 Jul; 16(1):167. PubMed ID: 27430714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.
    Feig DS; Donovan LE; Corcoy R; Murphy KE; Amiel SA; Hunt KF; Asztalos E; Barrett JFR; Sanchez JJ; de Leiva A; Hod M; Jovanovic L; Keely E; McManus R; Hutton EK; Meek CL; Stewart ZA; Wysocki T; O'Brien R; Ruedy K; Kollman C; Tomlinson G; Murphy HR;
    Lancet; 2017 Nov; 390(10110):2347-2359. PubMed ID: 28923465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Biochemical Markers of Glycemia to Predict Pregnancy Outcomes in Women With Type 1 Diabetes.
    Meek CL; Tundidor D; Feig DS; Yamamoto JM; Scott EM; Ma DD; Halperin JA; Murphy HR; Corcoy R;
    Diabetes Care; 2021 Mar; 44(3):681-689. PubMed ID: 33495292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters.
    Murphy HR
    Diabetologia; 2019 Jul; 62(7):1123-1128. PubMed ID: 31161344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of intermittently scanned continuous glucose monitoring to standard care in a cohort of pregnant women with type 1 diabetes: effect on glycaemic control and pregnancy outcomes.
    Perea V; Picón MJ; Megia A; Goya M; Wägner AM; Vega B; Seguí N; Montañez MD; Vinagre I
    Diabetologia; 2022 Aug; 65(8):1302-1314. PubMed ID: 35546211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycaemia in low-premixed insulin analogue type 2 diabetes patients in a real-world setting: are the CGM targets met?
    Krajnc M; Kravos Tramšek NA
    Eur J Med Res; 2023 Mar; 28(1):111. PubMed ID: 36882852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin pump therapy with and without continuous glucose monitoring in pregnant women with type 1 diabetes: a prospective observational Orchestra Foundation study in Poland.
    Cypryk K; Wender-Ozegowska E; Cyganek K; Sieradzki J; Skoczylas K; Chen X; Cordero TL; Shin J; Cohen O
    Acta Diabetol; 2023 Apr; 60(4):553-561. PubMed ID: 36653533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achieving the HbA1c Target Requires Longer Time in Range in Pregnant Women With Type 1 Diabetes.
    Ling P; Yang D; Gu N; Xiao X; Lu J; Liu F; Zhou Z; Huang Q; Zhao J; Zhang M; Hu J; Luo S; Weng J; Yan J; Zheng X
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4309-e4317. PubMed ID: 34244734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Continuous Glucose Monitoring Metrics With Pregnancy Outcomes in Patients With Preexisting Diabetes.
    Sanusi AA; Xue Y; McIlwraith C; Howard H; Brocato BE; Casey B; Szychowski JM; Battarbee AN
    Diabetes Care; 2024 Jan; 47(1):89-96. PubMed ID: 37782847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous Glucose Monitoring Metrics in High-Risk Pregnant Women with Type 2 Diabetes.
    McLean A; Barr E; Tabuai G; Murphy HR; Maple-Brown L
    Diabetes Technol Ther; 2023 Dec; 25(12):836-844. PubMed ID: 37902969
    [No Abstract]   [Full Text] [Related]  

  • 12. Pumps or Multiple Daily Injections in Pregnancy Involving Type 1 Diabetes: A Prespecified Analysis of the CONCEPTT Randomized Trial.
    Feig DS; Corcoy R; Donovan LE; Murphy KE; Barrett JFR; Sanchez JJ; Wysocki T; Ruedy K; Kollman C; Tomlinson G; Murphy HR;
    Diabetes Care; 2018 Dec; 41(12):2471-2479. PubMed ID: 30327362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous glucose monitoring metrics and pregnancy outcomes in insulin-treated diabetes: A post-hoc analysis of the GlucoMOMS trial.
    Rademaker D; van der Wel AWT; van Eekelen R; Voormolen DN; de Valk HW; Evers IM; Mol BW; Franx A; Siegelaar SE; van Rijn BB; DeVries JH; Painter RC;
    Diabetes Obes Metab; 2023 Dec; 25(12):3798-3806. PubMed ID: 37735847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Glycemic Metrics Measured Simultaneously by Intermittently Scanned Continuous Glucose Monitoring and Real-Time Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes.
    Nørgaard SK; Mathiesen ER; Nørgaard K; Ringholm L
    Diabetes Technol Ther; 2021 Oct; 23(10):665-672. PubMed ID: 34086494
    [No Abstract]   [Full Text] [Related]  

  • 15. Continuous glucose monitoring parameters in pregnancy-related complications in patients with type 1 diabetes: a retrospective cohort study.
    Sibiak R; Mantaj U; Gutaj P; Zozulińska-Ziółkiewicz D; Wender-Ozegowska E
    Pol Arch Intern Med; 2023 Nov; 133(11):. PubMed ID: 37227218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost implications of continuous glucose monitoring in pregnant women with type 1 diabetes in 3 Canadian provinces: a posthoc cost analysis of the CONCEPTT trial.
    Ahmed RJ; Gafni A; Hutton EK; Hu ZJ; Sanchez JJ; Murphy HR; Feig DS;
    CMAJ Open; 2021; 9(2):E627-E634. PubMed ID: 34088734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Effectiveness of Continuous Glucose Monitoring in Pregnancies Affected by Type 1 Diabetes.
    Gao V; Snell-Bergeon JK; Malecha E; Johnson CA; Polsky S
    Diabetes Technol Ther; 2024 Aug; 26(8):526-535. PubMed ID: 38386433
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel Continuous Glucose Monitoring Metrics and Large-for-Gestational-Age Risk: An Exploratory Retrospective Cohort Study in Pregnancies with Type 1 Diabetes.
    Sibiak R; Gutaj P; Mrzewka-Rogacz B; Mantaj U; Wender-Ozegowska E
    Diabetes Technol Ther; 2022 Jan; 24(1):42-53. PubMed ID: 34524000
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes.
    Babaya N; Noso S; Hiromine Y; Taketomo Y; Niwano F; Yoshida S; Yasutake S; Kawabata Y; Ikegami H
    Sci Rep; 2021 Feb; 11(1):4006. PubMed ID: 33597626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
    JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.